Clinical Trial
doi: 10.1176/jnp.4.2.187.
Depression during treatment with beta-blockers: results from a double-blind placebo-controlled study
Affiliations
- PMID: 1627981
- DOI: 10.1176/jnp.4.2.187
Item in Clipboard
Clinical Trial
Depression during treatment with beta-blockers: results from a double-blind placebo-controlled study
J Neuropsychiatry Clin Neurosci.
1992 Spring.
Abstract
Depressive symptoms were rated during a double-blind placebo-controlled trial of nadolol for chronic aggression. Depressive symptoms were not significantly different in nadolol and placebo groups during any phase of the drug trial.
Similar articles
-
Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study.J Clin Psychiatry. 1992 Feb;53(2):41-6. J Clin Psychiatry. 1992. PMID: 1347291 Clinical Trial.
-
A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia.J Clin Psychiatry. 1991 Jun;52(6):255-60. J Clin Psychiatry. 1991. PMID: 1676029 Clinical Trial.
-
Nadolol in the treatment of aggression in chronic psychiatric inpatients.J Clin Psychiatry. 1993 Jun;54(6):235. J Clin Psychiatry. 1993. PMID: 8331093 No abstract available.
-
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230. J Clin Psychiatry. 2012. PMID: 22901348 Clinical Trial.
-
Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.Am J Psychiatry. 2002 Aug;159(8):1361-6. doi: 10.1176/appi.ajp.159.8.1361. Am J Psychiatry. 2002. PMID: 12153829 Clinical Trial.
Cited by
-
Drug-induced depression. Incidence, avoidance and management.Drug Saf. 1994 Mar;10(3):203-19. doi: 10.2165/00002018-199410030-00003. Drug Saf. 1994. PMID: 7913812 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
